PI3K
PI3K (gene symbol PIK3CA) is the catalytic subunit alpha of phosphatidylinositol 3-kinase, a lipid kinase that phosphorylates phosphoinositides at the 3 position of the inositol ring. By generating PIP3, it drives signalling cascades that control cell growth, survival, proliferation, motility and morphology. Browse Assay Genie's current range of PI3K research reagents below, or read on for the biology behind the target.
PI3K phosphorylates phosphatidylinositol and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides. Using ATP and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), it generates phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 recruits PH domain-containing proteins to the membrane, including AKT1 and PDPK1, and so activates signalling cascades involved in cell growth, survival, proliferation, motility and morphology.
The enzyme acts downstream of growth factors and is involved in AKT1 activation after stimulation by receptor tyrosine kinase ligands such as EGF, insulin, IGF1, VEGFA and PDGF. It also participates in signalling through insulin-receptor substrate (IRS) proteins. It is essential for endothelial cell migration during vascular development through VEGFA signalling, possibly by regulating RhoA activity, and is required for lymphatic vasculature development. Further roles include regulating invadopodia formation through the PDPK1-AKT1 pathway, supporting cardiomyogenesis and vasculogenesis in embryonic stem cells, and positively regulating phagocytosis and pinocytosis. Beyond its lipid kinase activity, it has a serine-protein kinase activity that autophosphorylates the p85alpha regulatory subunit and phosphorylates other proteins such as 4EBP1, H-Ras and the IL-3 beta c receptor.
Phosphatidylinositol 3-kinase is composed of an 85 kDa regulatory subunit and a 110 kDa catalytic subunit; the PI3K gene PIK3CA encodes the catalytic subunit, which also phosphorylates PtdIns and PtdIns4P. The protein belongs to the PI3/PI4-kinase family and is a member of the HGNC phosphatidylinositol 3-kinase family. The gene has been found to be oncogenic and has been implicated in cervical cancers. A pseudogene exists on chromosome 22. Mouse and rat orthologs are both named Pik3ca.
PI3K links receptor tyrosine kinase ligands such as EGF, insulin, IGF1, VEGFA and PDGF to AKT1 activation.
The PIK3CA gene has been found to be oncogenic and has been implicated in cervical cancers.
PI3K is essential for endothelial cell migration through VEGFA signalling and is required for lymphatic vasculature development.
The enzyme converts PtdIns(4,5)P2 to PIP3, making it a central subject for studying 3-phosphoinositide production.
PI3K is a lipid kinase that uses ATP to phosphorylate PtdIns(4,5)P2 and generate PIP3. PIP3 recruits PH domain-containing proteins such as AKT1 and PDPK1 to the membrane, activating pathways that regulate cell growth, survival, proliferation, motility and morphology.
The gene symbol is PIK3CA, with PI3K listed as an alias. Previous names include phosphoinositide-3-kinase, catalytic, alpha polypeptide. The protein is the catalytic subunit alpha, which pairs with an 85 kDa regulatory subunit in the phosphatidylinositol 3-kinase complex.
The PIK3CA gene has been found to be oncogenic and has been implicated in cervical cancers. Orthologs named Pik3ca exist in mouse and rat; check the datasheet of any product for its validated reactivity.
Other phosphoinositide kinases and PI3K regulatory subunits relevant to lipid signalling research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P42336; product specifications from Assay Genie datasheets.